This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Report Summary

Infection prevention's role in quality improvement initiatives is becoming more of an imperative within the overall efforts by healthcare institutions to preserve reimbursements tied to adverse events and other preventable conditions and infections. This report provides a brief overview of various aspects of healthcare reform pertinent to clinicians and infection preventionists tasked with achieving better patient outcomes.

Editor's Take

The changing healthcare landscape is being shaped by the Affordable Care Act, which has introduced significant drivers of change, including CMS readmission penalties, non-payment for healthcare-acquired conditions (HACs), as well as value-based purchasing. Key regulatory requirements include reportable quality metrics, measured patient outcomes, patient satisfaction reporting, plus evidence-based medicine practices/protocols. Within this new era, healthcare provider opportunities include lowering and/or eliminating readmissions, eliminating healthcare-acquired infections, increasing patient satisfaction and improving patient outcomes

Takeaways for Your Business

  • Review the various components of healthcare reform and the Affordable Care Act
  • Learn about U.S. healthcare system costs and quality
  • Discover the impact of value-based purchasing and healthcare reform on hospitals